WITHDRAWN—a resource for withdrawn and discontinued drugs
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Post-marketing drug withdrawals can be associated with various events, ranging from safety issues such as reported deaths or severe side-effects, to a multitude of non-safety problems including lack of efficacy, manufacturing, regulatory or business issues. During the last century, the majority of drugs voluntarily withdrawn from the market or prohibited by regulatory agencies was reported to be related to adverse drug reactions. Understanding the underlying mechanisms of toxicity is of utmost importance for current and future drug discovery. Here, we present WITHDRAWN, a resource for withdrawn and discontinued drugs publicly accessible at http://cheminfo.charite.de/withdrawn. Today, the database comprises 578 withdrawn or discontinued drugs, their structures, important physico-chemical properties, protein targets and relevant signaling pathways. A special focus of the database lies on the drugs withdrawn due to adverse reactions and toxic effects. For approximately one half of the drugs in the database, safety issues were identified as the main reason for withdrawal. Withdrawal reasons were extracted from the literature and manually classified into toxicity types representing adverse effects on different organs. A special feature of the database is the presence of multiple search options which will allow systematic analyses of withdrawn drugs and their mechanisms of toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common toxicity types associated with drug withdrawals in the United States and Europe are hepatic (21%), cardiovascular (16%), hematological (11%), neurological (9%), and carcinogenicity (8%) (Figure 2) (20).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705 · cited 1×
“Furthermore, the information on biological pathways and SNPs, including amino acid changes, peptide positions, MAFs, PolyPhen scores (37) and links to dbSNP, were added in the detailed record of a target.”
BackgroundData, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,092
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
An Algorithm for Subgraph Isomorphism
Ullmann, J. R. (1976) · Journal of the ACM · doi:10.1145/321921.321925 · Cited by 2,277
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
UniProt Knowledgebase: a hub of integrated protein data
Magrane, M., & Consortium, U. (2011) · Database · doi:10.1093/database/bar009 · Cited by 1,463
Cited by
ProTox-II: a webserver for the prediction of toxicity of chemicals
Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky318 · Cited by 3,195
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
ProTox 3.0: a webserver for the prediction of toxicity of chemicals
Banerjee, P., Kemmler, E., Dunkel, M., & Preissner, R. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae303 · Cited by 1,601
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
“The most common toxicity types associated with drug withdrawals in the United States and Europe are hepatic (21%), cardiovascular (16%), hematological (11%), neurological (9%), and carcinogenicity (8%) (Figure 2) (20).”
BackgroundADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness
Guan, L., Yang, H., Cai, Y., Sun, L., Di, P., Li, W., Liu, G., & Tang, Y. (2019) · MedChemComm · doi:10.1039/c8md00472b · Cited by 712
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0553-2 · Cited by 616
Chemical Aspects of Human and Environmental Overload with Fluorine
Han, J., Kiss, L., Mei, H., Remete, A. M., Ponikvar-Svet, M., Sedgwick, D. M., Roman, R., Fustero, S., Moriwaki, H., & Soloshonok, V. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01263 · Cited by 537
Organoids — Preclinical Models of Human Disease
Li, M., & Izpisua Belmonte, J. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806175 · Cited by 355
Bordon, K. D. C. F., Cologna, C. T., Fornari-Baldo, E. C., Pinheiro-Júnior, E. L., Cerni, F. A., Amorim, F. G., Anjolette, F. A. P., Cordeiro, F. A., Wiezel, G. A., Cardoso, I. A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01132 · Cited by 303
Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy
Dallmann, R., Okyar, A., & Lévi, F. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.004 · Cited by 293
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Zhong, H., Chan, G., Hu, Y., Hu, H., & Ouyang, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040263 · Cited by 288
Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications
Mohammadpour, R., Dobrovolskaia, M. A., Cheney, D. L., Greish, K. F., & Ghandehari, H. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.006 · Cited by 280
Nanotoxicology and Nanosafety: Safety-by-Design and Testing at a Glance
Zielińska, A., Costa, B., Ferreira, M. V., Miguéis, D., Louros, J. M. S., Durazzo, A., Lucarini, M., Eder, P., V. Chaud, M., Morsink, M., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134657 · Cited by 245
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation
Vo, A. H., Van Vleet, T. R., Gupta, R. R., Liguori, M. J., & Rao, M. S. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00227 · Cited by 188
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.010 · Cited by 186
Zebrafish Embryos and Larvae as Alternative Animal Models for Toxicity Testing
Bauer, B., Mally, A., & Liedtke, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413417 · Cited by 179
Oleaga, C., Riu, A., Rothemund, S., Lavado, A., McAleer, C. W., Long, C. J., Persaud, K., Narasimhan, N. S., Tran, M., Roles, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.062 · Cited by 175
Development of Safe Drugs: The hERG Challenge
Kalyaanamoorthy, S., & Barakat, K. H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21445 · Cited by 174
Liu, X., Ye, K., van Vlijmen, H., Emmerich, M., IJzerman, A. P., & van Westen, G. J. P. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00561-9 · Cited by 146
HiPSC-derived multi-organoids-on-chip system for safety assessment of antidepressant drugs
Yin, F., Zhang, X., Wang, L., Wang, Y., Zhu, Y., Li, Z., Tao, T., Chen, W., Yu, H., & Qin, J. (2021) · Lab on a Chip · doi:10.1039/d0lc00921k · Cited by 139
A critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
Mohammadpour, R., Cheney, D. L., Grunberger, J. W., Yazdimamaghani, M., Jedrzkiewicz, J., Isaacson, K. J., Dobrovolskaia, M. A., & Ghandehari, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.027 · Cited by 129
Sala, L., Bellin, M., & Mummery, C. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13577 · Cited by 121
Human biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117
Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI)
Minerali, E., Foil, D. H., Zorn, K. M., Lane, T. R., & Ekins, S. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00326 · Cited by 113
The 2016 database issue ofNucleic Acids Researchand an updated molecular biology database collection
Rigden, D. J., Fernández, X. M., & Galperin, M. Y. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1356 · Cited by 112
Lei, T., Sun, H., Kang, Y., Zhu, F., Liu, H., Zhou, W., Wang, Z., Li, D., Li, Y., & Hou, T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00631 · Cited by 105
SuperDRUG2: a one stop resource for approved/marketed drugs
Siramshetty, V. B., Eckert, O. A., Gohlke, B.-O., Goede, A., Chen, Q., Devarakonda, P., Preißner, S., & Preißner, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1088 · Cited by 104
Self-citationTrends in small molecule drug properties: A developability molecule assessment perspective
Agarwal, P., Huckle, J. E., Newman, J., & Reid, D. L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103366 · Cited by 101
Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery
Feric, N. T., Pallotta, I., Singh, R., Bogdanowicz, D. R., Gustilo, M. M., Chaudhary, K. W., Willette, R. N., Chendrimada, T. P., Xu, X., Graziano, M. P., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz168 · Cited by 96
h-FIBER: Microfluidic Topographical Hollow Fiber for Studies of Glomerular Filtration Barrier
Xie, R., Korolj, A., Liu, C., Song, X., Lu, R. X. Z., Zhang, B., Ramachandran, A., Liang, Q., & Radisic, M. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01097 · Cited by 95
Drug induced mitochondrial dysfunction: Mechanisms and adverse clinical consequences
Vuda, M., & Kamath, A. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.10.005 · Cited by 93
From bumblebee to bioeconomy: Recent developments and perspectives for sophorolipid biosynthesis
Dierickx, S., Castelein, M., Remmery, J., De Clercq, V., Lodens, S., Baccile, N., De Maeseneire, S. L., Roelants, S. L. K. W., & Soetaert, W. K. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107788 · Cited by 88
Lei, T., Chen, F., Liu, H., Sun, H., Kang, Y., Li, D., Li, Y., & Hou, T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00317 · Cited by 84
DrugMetric: quantitative drug-likeness scoring based on chemical space distance
Li, B., Wang, Z., Liu, Z., Tao, Y., Sha, C., He, M., & Li, X. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae321 · Cited by 84
Siramshetty, V. B., Nguyễn, Ð.-T., Martinez, N. J., Southall, N. T., Simeonov, A. M., & Zakharov, A. V. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00884 · Cited by 80
Self-citationJaganathan, K., Tayara, H., & Chong, K. T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040832 · Cited by 77
In silico prediction of chemical reproductive toxicity using machine learning
Jiang, C., Yang, H., Di, P., Li, W., Tang, Y., & Liu, G. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3772 · Cited by 76
Natural products modulating the hERG channel: heartaches and hope
Kratz, J. M., Grienke, U., Scheel, O., Mann, S. A., & Rollinger, J. M. (2017) · Natural Product Reports · doi:10.1039/c7np00014f · Cited by 76
Animal Models for the Study of Human Disease
Morgan, S. J., Hutt, J. A., & Sura, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-1284-1_15 · Cited by 76
He, S., Zhang, C., Zhou, P., Zhang, X., Ye, T., Wang, R., Sun, G., & Sun, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153633 · Cited by 75
Mouse Models for Drug Discovery. Can New Tools and Technology Improve Translational Power?
Zuberi, A. R., & Lutz, C. M. (2016) · ILAR Journal · doi:10.1093/ilar/ilw021 · Cited by 74
Patrick, M. T., Raja, K., Miller, K., Sotzen, J., Gudjonsson, J. E., Elder, J. T., & Tsoi, L. C. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.09.018 · Cited by 73
Feng, H., Zhang, L., Li, S., Liu, L., Yang, T., Yang, P., Zhao, J. H., Arkin, I. T., & Liu, H. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.01.002 · Cited by 68
MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction
Han, C., Wang, C.-C., Huang, L., & Chen, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad215 · Cited by 68
Current limitations and future opportunities for prediction of DILI from in vitro
Funk, C., & Roth, A. B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1874-9 · Cited by 67
Long‐Term Electrical and Mechanical Function Monitoring of a Human‐on‐a‐Chip System
Oleaga, C., Lavado, A., Riu, A., Rothemund, S., Carmona‐Moran, C. A., Persaud, K., Yurko, A., Lear, J., Narasimhan, N. S., Long, C. J., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201805792 · Cited by 63
Mora, J. R., Marrero‐Ponce, Y., García‐Jacas, C. R., & Causado, A. S. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00030 · Cited by 61
Lee, S. Y., & Yoo, S. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-023-00796-8 · Cited by 60
The Catch-22 of Predicting hERG Blockade Using Publicly Accessible Bioactivity Data
Siramshetty, V. B., Chen, Q., Devarakonda, P., & Preißner, R. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00150 · Cited by 60
Self-citationSelf-contained, low-cost Body-on-a-Chip systems for drug development
Wang, Y. I., Oleaga, C., Long, C. J., Esch, M. B., McAleer, C. W., Miller, P. G., Hickman, J. J., & Shuler, M. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694101 · Cited by 59
“The current preclinical and clinical models fail to predict the toxicity in advance, reflected in the number of withdrawn drugs due to cardiotoxicity observations after market release.(76) Trying to overcome this problem, a human cardiac system was engineered to study basic physiology and toxicology of the two key car…”
BackgroundHu, Y., Zhu, T., Cui, H., & Cui, H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403762 · Cited by 57
Hsiao, Y., Su, B., & Tseng, Y. J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa160 · Cited by 56
Network integration and modelling of dynamic drug responses at multi-omics levels
Selevsek, N., Caiment, F., Nudischer, R., Gmuender, H., Agarkova, I., Atkinson, F. L., Bachmann, I., Baier, V., Barel, G., Bauer, C., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01302-8 · Cited by 55
The Promise of AI for DILI Prediction
Vall, A., Sabnis, Y. A., Shi, J., Class, R., Hochreiter, S., & Klambauer, G. (2021) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.638410 · Cited by 54
Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
Nair, D. G., & Weiskirchen, R. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb47010007 · Cited by 53
Survey of Similarity-Based Prediction of Drug-Protein Interactions
Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 52
Old drugs, new uses: Drug repurposing in hematological malignancies
Kale, V. P., Habib, H., Chitren, R. J., Patel, M., Pramanik, K. C., Jonnalagadda, S. C., Challagundla, K. B., & Pandey, M. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.005 · Cited by 52
Sahoo, A. K., Augusthian, P. D., Muralitharan, I., Vivek-Ananth, R. P., Kumar, K., Gaurav, K., Ranganathan, G., & Samal, A. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10550-1 · Cited by 50
In silico prediction of chemical neurotoxicity using machine learning
Jiang, C., Zhao, P., Li, W., Tang, Y., & Liu, G. (2020) · Toxicology Research · doi:10.1093/toxres/tfaa016 · Cited by 49
Heart-on-a-chip systems: disease modeling and drug screening applications
Butler, D., & Reyes, D. R. (2024) · Lab on a Chip · doi:10.1039/d3lc00829k · Cited by 47
In silico off-target profiling for enhanced drug safety assessment
Liu, J., Gui, Y., Rao, J., Sun, J., Wang, G., Ren, Q., Qu, N., Niu, B., Chen, Z., Sheng, X., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.002 · Cited by 47
Bioprinting of Human Liver‐Derived Epithelial Organoids for Toxicity Studies
Bouwmeester, M. C., Bernal, P. N., Oosterhoff, L. A., van Wolferen, M. E., Lehmann, V., Vermaas, M., Buchholz, M., Peiffer, Q. C., Malda, J., van der Laan, L. J. W., et al. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100327 · Cited by 46
Zhang, H., Ma, J., Liu, C., Ren, J.-X., & Ding, L. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.09.051 · Cited by 46
Kagawa, T., Shirai, Y., Oda, S., & Yokoi, T. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy200 · Cited by 45
Matore, B. W., Roy, P. P., & Singh, J. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2178510 · Cited by 42
Swain, S. S., Pati, S., & Hussain, T. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114173 · Cited by 42
Busquet, F., Härtung, T., Pallocca, G., Rovida, C., & Leist, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02787-2 · Cited by 42
Zhao, X., Sun, Y.-H. P., Zhang, R., Chen, Z., Hua, Y., Zhang, P., Guo, H., Cui, X., Huang, X., & Li, X. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01131 · Cited by 41
DBPP-Predictor: a novel strategy for prediction of chemical drug-likeness based on property profiles
Gu, Y., Wang, Y., Zhu, K., Li, W., Liu, G., & Tang, Y. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00800-9 · Cited by 41
Ghaleb, A., Aouidate, A., Ayouchia, H. B. E., Aarjane, M., Anane, H., & Stiriba, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1808530 · Cited by 41
High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition
Krishna, S., Borrel, A., Huang, R., Zhao, J., Xia, M., & Kleinstreuer, N. (2022) · Biology · doi:10.3390/biology11020209 · Cited by 40
Lagunin, A. A., Romanova, M. A., Zadorozhny, A. D., Kurilenko, N. S., Shilov, B. V., Pogodin, P. V., Ivanov, S. M., Filimonov, D. A., & Poroikov, V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01136 · Cited by 39
In silico prediction of chemical respiratory toxicity via machine learning
Wang, Z., Zhao, P., Zhang, X., Xu, X., Li, W., Liu, G., & Tang, Y. (2021) · Computational Toxicology · doi:10.1016/j.comtox.2021.100155 · Cited by 39
A k-nearest neighbor classification of hERG K+ channel blockers
Chavan, S., Abdelaziz, A., Wiklander, J. G., & Nicholls, I. A. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9898-z · Cited by 39
Dyballa, S., Miñana, R. M., Rubio-Brotons, M., Cornet, C., Pederzani, T., Escaramís, G., García-Serna, R., Mestres, J., & Terriente, J. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz165 · Cited by 39
Models of Idiosyncratic Drug-Induced Liver Injury
Yokoi, T., & Oda, S. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-015007 · Cited by 38
Web-Based Tools for Polypharmacology Prediction
Awale, M., & Reymond, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8891-4_15 · Cited by 38
Curvature facilitates podocyte culture in a biomimetic platform
Korolj, A., Laschinger, C. A., James, C., Hu, E., Velikonja, C., Smith, N., Gu, I., Ahadian, S., Willette, R. N., Radisic, M., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00495a · Cited by 37
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons
Huang, C. Y., Nicholson, M. W., Wang, J. Y., Ting, C. Y., Tsai, M. H., Cheng, Y. C., Liu, C. L., Chan, D. Z. H., Lee, Y. C., Hsu, C. C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110643 · Cited by 36
An Overview of Computational Methods, Tools, Servers, and Databases for Drug Repurposing
Sarvagalla, S., Syed, S. B., & Coumar, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00025-0 · Cited by 36
Farag, A. K., Hassan, A. H. E., Jeong, H., Kwon, Y., Choi, J. G., Oh, M. S., Park, K. D., Kim, Y. K., & Roh, E. J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.057 · Cited by 34
Lane, S., Lynn, E., & Shakir, S. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019759 · Cited by 33
Masia, F., Pope, I., Watson, P., Langbein, W., & Borri, P. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04039 · Cited by 33
Cotovio, J. P., & Fernandes, T. G. (2020) · Bioengineering · doi:10.3390/bioengineering7020036 · Cited by 32
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac124.48714887 · Cited by 32
George, S. A., Lin, Z., & Efimov, I. R. (2022) · Communications Biology · doi:10.1038/s42003-022-03279-y · Cited by 32
Azad, I., Jafri, A., Khan, T., Akhter, Y., Arshad, M., Hassan, F., Ahmad, N. S., Khan, A. R., & Nasibullah, M. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.08.049 · Cited by 32
Su, R., Yang, H., Wei, L., Chen, S., & Zou, Q. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010402 · Cited by 31
García‐Jacas, C. R., Marrero‐Ponce, Y., Cortés‐Guzmán, F., Suárez‐Lezcano, J., Martínez-Rios, F., García‐González, L. A., Pupo-Meriño, M., & Martínez‐Mayorga, K. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00011 · Cited by 31
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
Goldring, C. E., Russomanno, G., Pin, C., Trairatphisan, P., Beattie, K. A., Fisher, C., Piñero, J., Brennan, R., Clausznitzer, D., Copple, I. M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01308-z · Cited by 28
Artificial intelligence uncovers carcinogenic human metabolites
Mittal, A., Mohanty, S. K., Gautam, V., Arora, S., Saproo, S., Gupta, R., Sivakumar, R., Garg, P., Aggarwal, A., Raghavachary, P., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01110-7 · Cited by 28
Whitworth, C. P., & Polacheck, W. J. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2294947 · Cited by 27
In silico analysis of alternative splicing on drug-target gene interactions
Ji, Y., Mishra, R. K., & Davuluri, R. V. (2020) · Scientific Reports · doi:10.1038/s41598-019-56894-x · Cited by 27
Assessment of Drug-Induced Liver Injury through Cell Morphology and Gene Expression Analysis
Lejal, V., Cerisier, N., Rouquié, D., & Taboureau, O. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00381 · Cited by 27
Zebrafish: An emerging whole-organism screening tool in safety pharmacology
Nikam, V. S., Singh, D., Takawale, R., & Ghante, M. R. (2020) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_482_19 · Cited by 26
Drug Repositioning Using Computer-aided Drug Design (CADD)
Rawat, S., Subramaniam, K., Subramanian, S. K., Saravanan, S., Dhanabalan, S., Chidambaram, S. K. M., Stalin, B., Roy, A., Nagaprasad, N., Aruna, M., et al. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230821103601 · Cited by 26
Sano, T., Masuda, Y., Yasuno, H., Shinozawa, T., Watanabe, T., & Kakehi, M. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab122 · Cited by 26
Kim, H., & Park, H. (2025) · Toxicological Research · doi:10.1007/s43188-024-00275-8 · Cited by 25
Metadata
- Authors
- Siramshetty, V. B., Nickel, J., Omieczynski, C., Gohlke, B.-O., Drwal, M. N., & Preissner, R.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Drwal, Malgorzata N.
- Preissner, Robert
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-08
- Volume
- 44
- Issue
- D1
- Pages
- D1080-D1086
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702851
- OpenAlex
- W2147670638
- Cited by
- 286
- References
- 45
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 35 · 2023: 36 · 2022: 27 · 2021: 28 · 2020: 37 · 2019: 24 · 2018: 30 · 2017: 12 · 2016: 12 · 2015: 1
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by-nc)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- drug withdrawal, adverse drug reactions, drug toxicity, toxicity mechanisms, drug safety, drug discovery, chemical databases, protein targets, signaling pathways, physicochemical properties
- MeSH terms
- Pharmaceutical Preparations, Humans, Proteins, Signal Transduction, Internet, Polymorphism, Single Nucleotide, Drug Recalls, Safety-Based Drug Withdrawals, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.